https://www.medday-pharma.com/ 2023-06-26T09:12:19+00:00 https://www.medday-pharma.com/happy-family-store-commence-les-livraisons-de-medicaments-francais/ 2025-10-17T15:22:37+00:00 https://www.medday-pharma.com/for-patients-families/mexglobal-review/ 2026-03-27T10:28:57+00:00 https://www.medday-pharma.com/about-us/partnerships-and-investor-relations 2024-06-17T08:12:59+00:00 https://www.medday-pharma.com/news-and-events/medday-and-happy-family-store-offer-mtm-services/ 2026-04-28T14:31:21+00:00 https://www.medday-pharma.com/sitemap/ 2023-05-18T11:18:32+00:00 https://www.medday-pharma.com/site-map/ 2023-05-18T11:18:40+00:00 https://www.medday-pharma.com/research-development/research-platform/ 2023-05-18T03:34:51+00:00 https://www.medday-pharma.com/research-development/publications/ 2023-05-18T11:18:32+00:00 https://www.medday-pharma.com/research-development/pipeline/md1105/publications-literature/ 2023-05-18T03:32:28+00:00 https://www.medday-pharma.com/research-development/pipeline/md1105/alzheimers-disease/ 2023-05-18T03:35:07+00:00 https://www.medday-pharma.com/research-development/pipeline/md1105/ 2023-05-18T03:24:15+00:00 https://www.medday-pharma.com/research-development/pipeline/md1103/publications-literature/ 2023-05-18T03:22:38+00:00 https://www.medday-pharma.com/research-development/pipeline/md1103/autism/ 2023-05-18T03:23:33+00:00 https://www.medday-pharma.com/research-development/pipeline/md1103/ 2023-05-18T03:18:41+00:00 https://www.medday-pharma.com/research-development/pipeline/md1003/publications-literature/ 2023-05-18T11:18:32+00:00 https://www.medday-pharma.com/research-development/pipeline/md1003/multiple-sclerosis/ 2023-05-18T03:19:24+00:00 https://www.medday-pharma.com/research-development/pipeline/md1003/adrenomyeloneuropathy/ 2023-05-18T03:24:38+00:00 https://www.medday-pharma.com/research-development/pipeline/md1003/ 2023-05-18T03:33:37+00:00 https://www.medday-pharma.com/research-development/pipeline/ 2023-05-18T03:21:23+00:00 https://www.medday-pharma.com/research-development/information-for-healthcare-professionals/ 2023-05-18T03:18:25+00:00 https://www.medday-pharma.com/research-development/discovery-at-medday/ 2023-08-22T12:55:52+00:00 https://www.medday-pharma.com/research-development/ 2023-05-18T11:13:10+00:00 https://www.medday-pharma.com/personality/philippe-goupit/ 2023-05-18T03:10:32+00:00 https://www.medday-pharma.com/personality/janet-vergis/ 2023-05-18T03:15:20+00:00 https://www.medday-pharma.com/personality/george-garibaldi/ 2023-05-18T11:53:00+00:00 https://www.medday-pharma.com/personality/catherine-moukheibir/ 2023-05-18T03:10:55+00:00 https://www.medday-pharma.com/legal-terms/ 2023-05-18T04:26:14+00:00 https://www.medday-pharma.com/for-patients-families/whats-behind-the-metabolism-approach/ 2024-11-26T16:39:49+00:00 https://www.medday-pharma.com/for-patients-families/expanded-access-policy-us-only/ 2023-05-18T11:19:05+00:00 https://www.medday-pharma.com/for-patients-families/clinical-trials/ 2023-05-18T11:16:40+00:00 https://www.medday-pharma.com/for-patients-families/ 2025-12-30T10:59:55+00:00 https://www.medday-pharma.com/for-patients/ 2023-05-18T04:19:25+00:00 https://www.medday-pharma.com/for-healthcare-professionals/ 2023-05-18T04:25:06+00:00 https://www.medday-pharma.com/contacts/ 2023-05-18T04:19:18+00:00 https://www.medday-pharma.com/contact/question-on-product-quality/ 2023-05-18T04:19:09+00:00 https://www.medday-pharma.com/contact/medical-information-product-or-disease-related/ 2023-05-18T04:31:51+00:00 https://www.medday-pharma.com/contact/declare-an-adverse-event/ 2023-05-18T04:16:37+00:00 https://www.medday-pharma.com/contact-us/ 2023-05-18T11:18:32+00:00 https://www.medday-pharma.com/about/who-we-are 2023-05-18T04:11:35+00:00 https://www.medday-pharma.com/about/team/sandrine-aros-calt/ 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/raphael-wisniewski/ 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/rafa-le-tordjman 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/rafa%c3%a8le-tordjman/ 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/philippe-goupit 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/joseph-helgoule/ 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/jean-jacques-garaud 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/hermine-cadence/ 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/guillaume-brion-md 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/fr-d-ric-sedel-md 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/emmanuel-simonot/ 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/elisabeth-gouguenheim/ 2023-05-18T10:28:50+00:00 https://www.medday-pharma.com/about/team/delphine-bernard/ 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/christophe-junot/ 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/chahra-louafi 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/catherine-moukheibir/ 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/benoit-colsh/ 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/benoit-colsch/ 2023-05-18T10:28:49+00:00 https://www.medday-pharma.com/about/team/ 2023-05-18T10:28:37+00:00 https://www.medday-pharma.com/about/patient-associations/ 2023-05-18T05:11:53+00:00 https://www.medday-pharma.com/about/management-team/sandrine-aros-calt/ 2023-05-18T05:14:37+00:00 https://www.medday-pharma.com/about/management-team/joseph-helgoule/ 2023-05-18T05:14:49+00:00 https://www.medday-pharma.com/about/management-team/hermine-cadence/ 2023-05-18T05:15:12+00:00 https://www.medday-pharma.com/about/management-team/guillaume-brion-md/ 2023-05-18T05:15:00+00:00 https://www.medday-pharma.com/about/management-team/guillaume-brion/ 2023-05-18T05:15:23+00:00 https://www.medday-pharma.com/about/management-team/fr-d-ric-sedel-md/ 2023-05-18T05:15:33+00:00 https://www.medday-pharma.com/about/management-team/fr-d-ric-sedel/ 2023-05-18T05:14:22+00:00 https://www.medday-pharma.com/about/management-team/emmanuel-simonot/ 2023-05-18T05:14:06+00:00 https://www.medday-pharma.com/about/management-team/delphine-bernard/ 2023-05-18T05:12:05+00:00 https://www.medday-pharma.com/about/management-team/christophe-junot/ 2023-05-18T05:13:00+00:00 https://www.medday-pharma.com/about/management-team/benoit-colsh/ 2023-05-18T05:12:50+00:00 https://www.medday-pharma.com/about/management-team/ 2023-05-18T05:13:39+00:00 https://www.medday-pharma.com/about/investors/ 2023-05-18T05:12:32+00:00 https://www.medday-pharma.com/about/board-of-directors/raphael-wisniewski 2023-05-18T05:12:42+00:00 https://www.medday-pharma.com/about/board-of-directors/rafa-le-tordjman/ 2023-05-18T10:27:48+00:00 https://www.medday-pharma.com/about/board-of-directors/philippe-goupit/ 2023-05-18T10:27:48+00:00 https://www.medday-pharma.com/about/board-of-directors/janet-vergis 2023-05-18T05:15:46+00:00 https://www.medday-pharma.com/about/board-of-directors/george-garibaldi 2023-05-18T05:17:27+00:00 https://www.medday-pharma.com/about/board-of-directors/chahra-louafi 2023-05-18T05:17:38+00:00 https://www.medday-pharma.com/about/board-of-directors/catherine-moukheibir 2023-05-18T05:08:13+00:00 https://www.medday-pharma.com/about/board-of-directors/ 2023-05-18T05:08:41+00:00 https://www.medday-pharma.com/about-us/who-we-are/ 2023-05-18T05:08:58+00:00 https://www.medday-pharma.com/about-us/scientific-advisory-board/ 2023-05-18T11:09:49+00:00 https://www.medday-pharma.com/about-us/our-story/ 2023-05-18T10:56:09+00:00 https://www.medday-pharma.com/about-us/management-team/ 2023-05-18T05:42:08+00:00 https://www.medday-pharma.com/about-us/investors/ 2023-05-18T05:09:29+00:00 https://www.medday-pharma.com/about-us/group-management/ 2023-05-18T11:05:20+00:00 https://www.medday-pharma.com/about-us/find-us/ 2023-05-18T05:20:35+00:00 https://www.medday-pharma.com/about-us/executive-committee/ 2023-05-18T10:22:55+00:00 https://www.medday-pharma.com/about-us/directors/ 2023-05-18T10:22:55+00:00 https://www.medday-pharma.com/about-us/board-of-directors/ 2023-05-18T10:22:55+00:00 https://www.medday-pharma.com/about-us/ 2023-05-18T10:54:02+00:00 https://www.medday-pharma.com/news-and-events/multiple-sclerosis-progression-symptoms-and-treatment-options/ 2026-06-10T10:48:31+00:00 https://www.medday-pharma.com/news-and-events/medday-and-happy-family-store-offer-mtm-services/ 2023-12-19T10:45:31+00:00 https://www.medday-pharma.com/news-and-events/positive-preclinical-data-with-md1003-high-dose-pharmaceutical-grade-biotin-in-x-linked-adrenoleukodystrophy-to-be-presented-at-european-committee-for-treatment-and-research-in-multiple-sclerosis-2016/ 2023-05-18T11:18:40+00:00 https://www.medday-pharma.com/news-and-events/medday-to-webcast-results-of-its-pivotal-phase-iii-study-of-md1003-in-patients-with-progressive-multiple-sclerosis/ 2023-05-18T11:18:40+00:00 https://www.medday-pharma.com/news-and-events/medday-to-present-pivotal-phase-iii-data-in-progressive-multiple-sclerosis-at-aan-annual-meeting/ 2023-05-18T11:18:40+00:00 https://www.medday-pharma.com/news-and-events/medday-strengthens-its-board-with-two-senior-non-executive-directors 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-secures-34-million-38-5m-new-funding 2023-05-18T07:46:44+00:00 https://www.medday-pharma.com/news-and-events/medday-reports-positive-pivotal-phase-iii-study-results-with-md1003-in-patients-with-progressive-multiple-sclerosis 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-reports-full-data-from-pivotal-phase-iib-iii-ms-spi-ms-on-studies-with-md1003-in-multiple-sclerosis-at-aan 2023-05-18T07:47:17+00:00 https://www.medday-pharma.com/news-and-events/medday-reports-additional-positive-data-of-its-pivotal-phase-iii-study-with-md1003-in-patients-with-progressive-multiple-sclerosis/ 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-reports-additional-positive-analyses-of-its-pivotal-study-with-md1003-in-patients-with-primary-and-secondary-progressive-multiple-sclerosis 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-provides-update-on-pipeline-progress 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-provides-update-on-pioneering-pivotal-phase-iii-study-design-in-progressive-multiple-sclerosis/ 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-provides-update-on-ms-on-study-of-md-1003/ 2023-05-18T07:48:59+00:00 https://www.medday-pharma.com/news-and-events/medday-pharmaceuticals-r-alise-une-nouvelle-lev-e-de-fonds-de-34-millions-deuros/ 2023-05-18T07:49:15+00:00 https://www.medday-pharma.com/news-and-events/medday-notes-acceptance-of-manuscript-into-journal-of-multiple-sclerosis-and-related-disorders/ 2023-05-18T11:18:32+00:00 https://www.medday-pharma.com/news-and-events/medday-nomme-christian-chavy-dirigeant-reconnu-de-lindustrie-pharmaceutique-au-poste-de-directeur-g-n-ral/ 2023-05-18T07:49:46+00:00 https://www.medday-pharma.com/news-and-events/medday-boosts-its-research-capabilities-with-profilomic-acquisition 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-attends-european-academy-of-neurology-2016-and-presents-extension-phase-results-of-the-ms-spi-trial 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-appoints-philippe-goupit-to-its-board-of-directors/ 2023-05-18T07:50:33+00:00 https://www.medday-pharma.com/news-and-events/medday-appoints-industry-leader-christian-chavy-as-chief-executive-officer/ 2023-05-18T07:51:22+00:00 https://www.medday-pharma.com/news-and-events/medday-announces-publication-of-md1003-phase-iib-iii-study-in-the-multiple-sclerosis-journal 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-announces-its-pivotal-phase-iii-study-of-md1003-in-patients-with-progressive-multiple-sclerosis-meets-primary-endpoint 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-annonce-que-son-tude-pivot-de-phase-iii-sur-le-md1003-chez-des-patients-atteints-de-scl-rose-en-plaques-progressive-a-donn-des-r-sultats-positifs 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-annonce-avoir-atteint-le-crit-re-principal-de-son-tude-pivot-de-phase-iii-sur-le-md1003-chez-des-patients-pr-sentant-une-scl-rose-en-plaques-progressive/ 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/news-and-events/medday-and-dsm-announce-a-partnership-to-produce-pharmaceutical-grade-d-biotin-to-treat-progressive-multiple-sclerosis 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/2020/05/20/2109/ 2023-05-18T07:52:58+00:00 https://www.medday-pharma.com/2020/03/10/medday-reports-top-line-data-from-phase-iii-trial-spi2-for-treatment-of-progressive-forms-of-multiple-sclerosis/ 2023-05-18T11:18:33+00:00 https://www.medday-pharma.com/2019/12/12/medday-reports-last-patient-study-visit-in-second-phase-3-clinical-trial-with-md1003-an-important-milestone-towards-completion-of-the-spi2-study-in-progressive-multiple-sclerosis/ 2023-05-18T11:18:32+00:00 https://www.medday-pharma.com/2015/04/27/medday-to-webcast-results-of-its-pivotal-phase-iii-study-of-md1003-in-patients-with-progressive-multiple-sclerosis/ 2023-05-18T11:18:32+00:00 https://www.medday-pharma.com/2018/11/09/medday-pharmaceuticals-announces-full-patient-enrollment-for-md1003-phase-iii-clinical-trial-spi2-in-progressive-multiple-sclerosis/ 2023-05-18T11:18:32+00:00